GONUTS has been updated to MW1.31 Most things seem to be working but be sure to report problems.

Have any questions? Please email us at ecoliwiki@gmail.com

TableEdit

Jump to: navigation, search

PMID:20141836

You don't have sufficient rights on this wiki to edit tables. Perhaps you need to log in. Changes you make in the Table editor will not be saved back to the wiki

See Help for Help on this wiki. See the documentation for how to use the table editor

Citation

Tu, W, Xu, X, Peng, L, Zhong, X, Zhang, W, Soundarapandian, MM, Balel, C, Wang, M, Jia, N, Zhang, W, Lew, F, Chan, SL, Chen, Y and Lu, Y (2010) DAPK1 interaction with NMDA receptor NR2B subunits mediates brain damage in stroke. Cell 140:222-34

Abstract

N-methyl-D-aspartate (NMDA) receptors constitute a major subtype of glutamate receptors at extrasynaptic sites that link multiple intracellular catabolic processes responsible for irreversible neuronal death. Here, we report that cerebral ischemia recruits death-associated protein kinase 1 (DAPK1) into the NMDA receptor NR2B protein complex in the cortex of adult mice. DAPK1 directly binds with the NMDA receptor NR2B C-terminal tail consisting of amino acid 1292-1304 (NR2B(CT)). A constitutively active DAPK1 phosphorylates NR2B subunit at Ser-1303 and in turn enhances the NR1/NR2B receptor channel conductance. Genetic deletion of DAPK1 or administration of NR2B(CT) that uncouples an activated DAPK1 from an NMDA receptor NR2B subunit in vivo in mice blocks injurious Ca(2+) influx through NMDA receptor channels at extrasynaptic sites and protects neurons against cerebral ischemic insults. Thus, DAPK1 physically and functionally interacts with the NMDA receptor NR2B subunit at extrasynaptic sites and this interaction acts as a central mediator for stroke damage.

Links

PubMed PMC2820131 Online version:10.1016/j.cell.2009.12.055

Keywords

Animals; Apoptosis Regulatory Proteins/antagonists & inhibitors; Apoptosis Regulatory Proteins/genetics; Apoptosis Regulatory Proteins/metabolism; Brain/metabolism; Brain/pathology; Brain Ischemia/drug therapy; Brain Ischemia/metabolism; Calcium-Calmodulin-Dependent Protein Kinases/antagonists & inhibitors; Calcium-Calmodulin-Dependent Protein Kinases/genetics; Calcium-Calmodulin-Dependent Protein Kinases/metabolism; Cell Death; Mice; Neurons/cytology; Neurons/metabolism; Peptides/metabolism; Receptors, N-Methyl-D-Aspartate/metabolism; Recombinant Proteins/genetics; Recombinant Proteins/metabolism; Stroke/drug therapy; Stroke/metabolism; Stroke/pathology; tat Gene Products, Human Immunodeficiency Virus/genetics; tat Gene Products, Human Immunodeficiency Virus/metabolism

public



Cancel